
|Podcasts|July 7, 2021
Getting Clinical Trials, Cancer Screenings Back on Track with Tech to Avoid Wave of Patients Post-COVID
Author(s)Briana Contreras
MHE Associate Editor, Briana Contreras, spoke with CEO of Inteliquet, a cancer solutions provider that strives to match patients to clinical trials accurately and promptly in healthcare, Marie Lamont. In this episode Marie discusses the challenges that have affected clinical trials and cancer screenings and how to get trials back on track through technology to avoid the wave of undiagnosed patients post-COVID. She also shared how broadening them through diversity can improve trials.
Advertisement
To listen to more episodes featured on Tuning Into The C-Suite, visit us on
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Payers lean on step therapy, formulary exclusions as IRA reshapes Part D benefit design
2
1,700 sites closed, 77,000 fewer children received PEPFAR-supported treatment after PEPFAR disruption | IAS 2026
3
Anti-VEGF injection costs driven by missed work, travel vs drug costs | ASRS 2026
4
Redemplo cuts triglycerides, pancreatitis risk in severe hypertriglyceridemia
5



























